Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance

Cell Metabolism
Michael J KraakmanMark A Febbraio

Abstract

Interleukin-6 (IL-6) plays a paradoxical role in inflammation and metabolism. The pro-inflammatory effects of IL-6 are mediated via IL-6 "trans-signaling," a process where the soluble form of the IL-6 receptor (sIL-6R) binds IL-6 and activates signaling in inflammatory cells that express the gp130 but not the IL-6 receptor. Here we show that trans-signaling recruits macrophages into adipose tissue (ATM). Moreover, blocking trans-signaling with soluble gp130Fc protein prevents high-fat diet (HFD)-induced ATM accumulation, but does not improve insulin action. Importantly, however, blockade of IL-6 trans-signaling, unlike complete ablation of IL-6 signaling, does not exacerbate obesity-induced weight gain, liver steatosis, or insulin resistance. Our data identify the sIL-6R as a critical chemotactic signal for ATM recruitment and suggest that selectively blocking IL-6 trans-signaling may be a more favorable treatment option for inflammatory diseases, compared with current treatments that completely block the action of IL-6 and negatively impact upon metabolic homeostasis.

References

Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·I F CharoS R Coughlin
Mar 28, 1998·The Journal of Experimental Medicine·T AlonziG Ciliberto
Dec 20, 2000·European Journal of Biochemistry·T JostockS Rose-John
Jan 12, 2002·Nature Medicine·Ville WalleniusJohn-Olov Jansson
Jul 2, 2003·The Journal of Biological Chemistry·Vance MatthewsStefan Rose-John
Dec 18, 2003·The Journal of Clinical Investigation·Stuart P WeisbergAnthony W Ferrante
Dec 18, 2003·The Journal of Clinical Investigation·Haiyan XuHong Chen
Jan 22, 2005·Science·Mitchell A Lazar
May 1, 2007·Expert Opinion on Therapeutic Targets·Stefan Rose-JohnDirk Seegert
Jul 13, 2007·Journal of the American Society of Nephrology : JASN·Onkar KulkarniHans-Joachim Anders
Aug 25, 2007·The Journal of Clinical Investigation·Ja-Young KimPhilipp E Scherer
Sep 6, 2007·The Journal of Clinical Investigation·Yihai Cao
Mar 23, 2010·Clinical Pharmacology and Therapeutics·M A FebbraioB K Pedersen
Nov 15, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Harald SchuettKarsten Grote
Aug 7, 2012·Nature Medicine·Saswata TalukdarJerrold M Olefsky
Jun 12, 2013·Cell Metabolism·Diane Mathis
Sep 18, 2013·Diabetes, Obesity & Metabolism·M J KraakmanM A Febbraio

❮ Previous
Next ❯

Citations

Feb 13, 2016·Journal of Hepatology·Dirk Schmidt-Arras, Stefan Rose-John
Nov 26, 2015·Cell Metabolism·Andrew J MurphySeth L Masters
Nov 11, 2015·Nature Reviews. Endocrinology·Denise E Lackey, Jerrold M Olefsky
Dec 5, 2015·Frontiers in Physiology·Luiz H A Cavalcante-SilvaSandra Rodrigues-Mascarenhas
Nov 4, 2015·Seminars in Cell & Developmental Biology·Maria TsoliGraham R Robertson
Jul 30, 2015·European Journal of Immunology·Felix M WensveenBojan Polić
Jul 21, 2015·Cytokine & Growth Factor Reviews·Fred Schaper, Stefan Rose-John
Apr 22, 2015·Nature Immunology·Christopher A Hunter, Simon A Jones
Jun 29, 2016·Clinical & Translational Immunology·Michael J KraakmanAndrew J Murphy
Jul 5, 2016·Cell Reports·Maria MavilioMassimo Federici
Aug 12, 2016·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·John P Thyfault, David C Wright
Nov 8, 2016·Molecular Metabolism·Robert S Lee-YoungMark A Febbraio
Nov 3, 2016·Experimental Animals·Taiki MoriKen Watanabe
Oct 23, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juri BergmannDirk Schmidt-Arras
Feb 18, 2017·International Journal of Molecular Sciences·Xuan SunRuifang Niu
Apr 7, 2017·Journal of Molecular Endocrinology·Melanie SapochnikEduardo Arzt
May 13, 2017·Nature Reviews. Endocrinology·Kirthana Ganeshan, Ajay Chawla
Apr 1, 2017·The Journal of Endocrinology·Greg M KowalskiClinton R Bruce
Mar 3, 2017·Mediators of Inflammation·Mario Luca MorieriGiovanni Zuliani
Jul 29, 2017·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Andrew M F JohnsonPingping Li
Jul 5, 2017·Clinical Pharmacology and Therapeutics·Stefan Rose-John
Jun 14, 2017·International Journal of Molecular Sciences·Megan YuYu-Min Kuo
Dec 2, 2017·International Journal of Molecular Sciences·Shafqat Rasul ChaudhrySajjad Muhammad
Feb 24, 2018·The Journal of Experimental Medicine·Stefanie SchmidtStefan Rose-John
Aug 23, 2017·Cancer Immunology, Immunotherapy : CII·Xiao-Long FuYong-Liang Zhao
Mar 7, 2018·Inflammopharmacology·Mohamad Akbari, Vahideh Hassan-Zadeh
Aug 25, 2017·Science Advances·Kara L PerksAleksandra Filipovska
Jan 23, 2016·The Journal of Experimental Biology·Lena CronMark A Febbraio
May 17, 2018·Pulmonary Circulation·Levi D MastonLaura V Gonzalez Bosc
Jun 2, 2018·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Aaron RamanTimothy J Fairchild
Sep 25, 2017·Endocrine Reviews·Abdikarim Abdullahi, Marc G Jeschke
Jun 24, 2016·Endocrine Reviews·Margherita MaffeiFerruccio Santini
Jun 16, 2017·Nature Reviews. Rheumatology·Stefan Rose-JohnLeonard Calabrese
Sep 27, 2019·Nature·Maria FindeisenMark A Febbraio
Oct 31, 2018·Scientific Reports·Linjie WangYan Wang
Nov 7, 2019·Cancers·Neele Schumacher, Stefan Rose-John
Jan 12, 2016·Current Opinion in Rheumatology·Xiao LiuSimon A Jones
Dec 24, 2015·Medicine and Science in Sports and Exercise·Inga Bae-GartzEva Hucklenbruch-Rother
Aug 20, 2019·EMBO Reports·Judit Castillo-ArmengolIsabel C Lopez-Mejia

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.